Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro

about

Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro

Item

http://www.wikidata.org/entity/Q37003594

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro

@en

Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro.

@nl

type

Item

label

Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro

@en

Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro.

@nl

prefLabel

Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro

@en

Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro.

@nl

P1476

Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro

@en

P2093

Cheng-Ke Huang

http://www.w3.org/2001/XMLSchema#string

Da-Peng Dai

http://www.w3.org/2001/XMLSchema#string

Guo-Xin Hu

http://www.w3.org/2001/XMLSchema#string

Jian-Ping Cai

http://www.w3.org/2001/XMLSchema#string

Li Wang

http://www.w3.org/2001/XMLSchema#string

Ren-Ai Xu

http://www.w3.org/2001/XMLSchema#string

Yun-Yun Zhan

http://www.w3.org/2001/XMLSchema#string

Zhe Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of human cytochrome P450 2D6

Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance.

CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects.

Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.

Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity.

New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme.

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.

Polymorphism of human cytochrome P450 enzymes and its clinical impact.

P304

1909-1916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S106175

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27354764

http://www.w3.org/2001/XMLSchema#string

P932

4907640

http://www.w3.org/2001/XMLSchema#string